Delivering powdered, needle-free vaccines.

Delivering DNA and RNA Vaccines Where and How They Are Needed.

INTRODUCING ORLANCE MACH-1 ™​

LOW-DOSE, NEEDLE-FREE POWDERED NUCLEIC ACID VACCINES WITHOUT COLD CHAIN REQUIREMENTS.

Orlance aims to deliver powdered, needle-free, shelf-stable, nucleic acid vaccines (DNA and/or RNA) with its epidermal vaccine delivery platform.

Read More
Download Our PDF

Meet Us At:

World Vaccine Congress, Barcelona
29 to 31 October, 2024.

BIO Investor Forum, San Francisco
15 to 16 October, 2024.

Society for Immunotherapy of Cancer, Houston
6 to 10 November, 2024.

Careers

Thank you for your interest in joining the Orlance team. While we currently do not have any openings, please check again another time.

Contact

© 2021 Orlance Inc. | Site by Malolo Design